# Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD

> **NCT05457049** · — · UNKNOWN · sponsor: **Guangdong Association of Clinical Trials** · enrollment: 180 (estimated)

## Conditions studied

- Non Small Cell Lung Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Molecular residual disease test

## Key facts

- **NCT ID:** NCT05457049
- **Lead sponsor:** Guangdong Association of Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-01
- **Primary completion:** 2023-08-01
- **Final completion:** 2025-08-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2022-09-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05457049

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05457049, "Adjuvant Therapy Omission for Resected NSCLC Patients With Longitudinal Undetectable MRD". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05457049. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*